SCHEMBL8287490

SCHEMBL8287490

O=c1cc(Nc2ccccc2)n(-c2ccccc2)c2cc(Oc3ccccc3)ncc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 1/20 0.38
CCND1 P24385 1/20 0.38
CCND2 P30279 1/20 0.38
CCND3 P30281 1/20 0.38
GSK3B P49841 3/20 0.36
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
PDE11A Q9HCR9 1/20 0.35
CYP1A2 P05177 4/20 0.34
CYP3A4 P08684 4/20 0.34
MEN1 O00255 3/20 0.34
ALDH1A1 P00352 3/20 0.34
KMT2A Q03164 3/20 0.34
CYP2C9 P11712 3/20 0.34
USP2 O75604 2/20 0.34
TSHR P16473 2/20 0.34
CYP2C19 P33261 1/20 0.34
CLK4 Q9HAZ1 1/20 0.34
MAPK1 P28482 2/20 0.33
MAPK8 P45983 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8360819 0.88 CDK4 (0.36) CDK4CCND1CCND2CCND3GSK3B
SCHEMBL8287576 0.87 GSK3B (0.39) CDK4CCND1CCND2CCND3GSK3B
SCHEMBL8285329 0.85 GSK3B (0.40) CDK4CCND1CCND2CCND3GSK3B
SCHEMBL8285261 0.85 GSK3B (0.38) CDK4CCND1CCND2CCND3GSK3B
SCHEMBL8287482 0.84 GSK3B (0.40) CDK4CCND1CCND2CCND3GSK3B
SCHEMBL8287459 0.84 GABRP (0.38) CDK4CCND1CCND2CCND3GSK3B
SCHEMBL8287240 0.84 HTT (0.41) CDK4CCND1CCND2CCND3GSK3B
SCHEMBL8285333 0.83 GSK3B (0.36) CDK4CCND1CCND2CCND3GSK3B
SCHEMBL8285316 0.83 PDE11A (0.40) CDK4CCND1CCND2CCND3GSK3B
SCHEMBL8285335 0.83 MAT2A (0.37) CDK4CCND1CCND2CCND3GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed